cryptotanshinone has been researched along with Shock, Septic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Z; Hou, X; Li, R; Liu, H; Qin, Q; Shi, W; Wang, J; Wang, Y; Wang, Z; Xiao, X; Xu, G; Yang, R; Zhan, X | 1 |
1 other study(ies) available for cryptotanshinone and Shock, Septic
| Article | Year |
|---|---|
Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases.
Topics: Animals; Cells, Cultured; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Liver; Macrophages; Male; Mice, Inbred C57BL; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Phenanthrenes; Reactive Oxygen Species; Shock, Septic; T-Lymphocytes, Regulatory; Th17 Cells; Tumor Necrosis Factor-alpha | 2021 |